Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Lung cancer, Mesothelioma, Non small cell lung cancer (NSCLC)
Closed
Phase 1/2
This trial is looking at a new drug called GSK3052230 alongside chemotherapy to treat lung cancer and mesothelioma. The trial is open to people who have a type of lung cancer called non small cell lung cancer and people who have mesothelioma in the chest (pleural mesothelioma).
Recruitment start: 9 October 2013
Recruitment end: 5 September 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Vanessa Potter
Experimental Cancer Medicine Centre (ECMC)
GlaxoSmithKline (GSK)
Last reviewed: 27 Oct 2016
CRUK internal database number: 12390
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
